FY2024 Earnings Estimate for U.S. Physical Therapy, Inc. (NYSE:USPH) Issued By Barrington Research

U.S. Physical Therapy, Inc. (NYSE:USPH) – Analysts at Barrington Research lowered their FY2024 earnings estimates for shares of U.S. Physical Therapy in a note issued to investors on Wednesday, October 9th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $2.20 for the year, down from their previous forecast of $2.30. Barrington Research currently has a “Outperform” rating and a $108.00 target price on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.51 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q4 2024 earnings at $0.56 EPS, Q1 2025 earnings at $0.43 EPS, Q2 2025 earnings at $0.77 EPS, Q3 2025 earnings at $0.61 EPS and Q4 2025 earnings at $0.69 EPS.

A number of other equities analysts also recently weighed in on the company. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Bank of America reissued a “neutral” rating and set a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday.

U.S. Physical Therapy Price Performance

Shares of USPH opened at $78.20 on Thursday. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. The company’s fifty day simple moving average is $84.76 and its 200 day simple moving average is $94.73. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63. The company has a market cap of $1.18 billion, a price-to-earnings ratio of 63.58, a PEG ratio of 3.97 and a beta of 1.39.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). The company had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm earned $0.76 EPS.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of hedge funds have recently added to or reduced their stakes in the stock. Canada Pension Plan Investment Board bought a new position in U.S. Physical Therapy in the 2nd quarter valued at about $28,000. Innealta Capital LLC acquired a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $30,000. Quest Partners LLC increased its stake in U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after acquiring an additional 337 shares during the last quarter. Northwest Bank & Trust Co acquired a new position in U.S. Physical Therapy during the fourth quarter valued at approximately $37,000. Finally, Quarry LP lifted its stake in U.S. Physical Therapy by 1,291.9% during the second quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after purchasing an additional 478 shares during the last quarter.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin bought 2,000 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were bought at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now owns 18,904 shares of the company’s stock, valued at $1,627,445.36. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were given a dividend of $0.44 per share. The ex-dividend date was Friday, August 23rd. This represents a $1.76 annualized dividend and a yield of 2.25%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 143.09%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.